▲ Peaking
Business
How Cardiologists’ High Hopes for Two Drugs Were Dashed
A major Cleveland Clinic-led trial reveals that a targeted drug successfully lowered lipoprotein(a) without reducing major heart events.
Lipoprotein(A)
4 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Health
Lp(a): The ‘sticky’ cholesterol gene you might not know you have
Recent reporting highlights lipoprotein(a) as a hidden genetic stroke and heart disease risk factor affecting one in five people.
◼ Archived
Health
🔮 fades ✓
New treatments for common cardiovascular risk factor near the market, with billions at stake
Lipoprotein(a) moves from lab curiosity to market‑ready target as new drugs and testing surge forward
◼ Archived
Health
🔮 fades ✓
The sneaky kind of cholesterol that may be threatening your heart health
Recent health reports highlight Lipoprotein(a) as a hidden genetic heart risk that can threaten cardiovascular health even when standard cholesterol levels appear normal.